Nkarta Inc. (NKTX) NASDAQ
$10.95 (0.14) (-1.26%)
Market Cap: $547.78M
As of 03/28/24 09:30 AM EDT. Market open.
Nkarta Inc. (NKTX)
NASDAQ
$10.95
(0.14) (-1.26%)
Market Cap: $547.78M
As of 03/28/24 09:30 AM EDT. Market open.
nkarta therapeutics seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. nkarta was founded on the proprietary, robust and well characterized natural killer (nk) cell expansion technology pioneered by dario campana. the company is focused ... read more
nkarta therapeutics seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. nkarta was founded on the proprietary, robust and well characterized natural killer (nk) cell expansion technology pioneered by dario campana. the company is focused on leveraging the natural potent power of nk cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. nkarta is combining its nk expansion platform technology with proprietary cell engineering technologies to build differentiated autologous and allogeneic cell therapy candidates for the treatment of cancer. founded in 2015, the company’s investors include sr one, nea and novo ventures. for more information, please visit the company’s website at www.nkartatx.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
HASTINGS PAUL J | Chief Executive Officer | Mar 04, 2024 | Option Exercise | $13.33 | 137,642 | 1,834,768 | 240,507 | Mar 05, 2024, 04:33 PM |
HASTINGS PAUL J | Chief Executive Officer | Mar 01, 2024 | Option Exercise | $13.00 | 12,358 | 160,654 | 378,149 | Mar 05, 2024, 04:33 PM |
Brandenberger Ralph | Chief Technical Officer | Mar 01, 2024 | Option Exercise | $3.89 | 6,763 | 26,308 | 88,339 | Mar 05, 2024, 04:26 PM |
Brandenberger Ralph | Chief Technical Officer | Mar 01, 2024 | Sale | $12.51 | 8,367 | 104,671 | 79,972 | Mar 05, 2024, 04:26 PM |
Trager James | Chief Scientific Officer | Feb 12, 2024 | Sale | $12.00 | 4,143 | 49,716 | 149,415 | Feb 14, 2024, 09:12 PM |
Shook David | Chief Medical Officer | Jan 16, 2024 | Sale | $8.74 | 3,552 | 31,044 | 114,980 | Jan 18, 2024, 04:45 PM |
Trager James | Chief Scientific Officer | Jan 16, 2024 | Sale | $8.74 | 4,560 | 39,854 | 153,558 | Jan 18, 2024, 04:43 PM |
Brandenberger Ralph | Chief Technical Officer | Jan 16, 2024 | Sale | $8.74 | 2,512 | 21,955 | 81,576 | Jan 18, 2024, 04:40 PM |
HASTINGS PAUL J | Chief Executive Officer | Jan 16, 2024 | Sale | $8.74 | 9,697 | 84,752 | 390,507 | Jan 18, 2024, 04:40 PM |
Hager Alicia J. | Chief Legal Officer | Jan 16, 2024 | Sale | $8.74 | 4,554 | 39,802 | 107,942 | Jan 18, 2024, 04:38 PM |
Shook David | Chief Medical Officer | Aug 21, 2023 | Sale | $1.83 | 1,331 | 2,436 | 60,532 | Aug 23, 2023, 04:11 PM |
Trager James | Chief Scientific Officer | Jun 20, 2023 | Sale | $4.85 | 439 | 2,129 | 100,118 | Jun 22, 2023, 04:26 PM |
Brandenberger Ralph | Chief Technical Officer | Jun 20, 2023 | Sale | $4.85 | 221 | 1,072 | 28,088 | Jun 22, 2023, 04:25 PM |
Hager Alicia J. | Chief Legal Officer | Jun 20, 2023 | Sale | $4.85 | 701 | 3,400 | 56,496 | Jun 22, 2023, 04:23 PM |
Shook David | Chief Medical Officer | Jun 20, 2023 | Sale | $4.85 | 439 | 2,129 | 61,863 | Jun 22, 2023, 04:22 PM |
Mahmood Nadir | See Remarks | Jun 20, 2023 | Sale | $4.85 | 526 | 2,551 | 85,776 | Jun 22, 2023, 04:21 PM |
HASTINGS PAUL J | Chief Executive Officer | Jun 20, 2023 | Sale | $4.85 | 1,704 | 8,264 | 313,402 | Jun 22, 2023, 04:20 PM |
Trager James | Chief Scientific Officer | Jan 17, 2023 | Sale | $5.49 | 1,115 | 6,121 | 98,557 | Jan 18, 2023, 07:05 PM |
Shook David | Chief Medical Officer | Jan 17, 2023 | Sale | $5.49 | 175 | 961 | 60,302 | Jan 18, 2023, 07:05 PM |
Mahmood Nadir | See Remarks | Jan 17, 2023 | Sale | $5.49 | 1,122 | 6,160 | 84,302 | Jan 18, 2023, 07:04 PM |
HASTINGS PAUL J | Chief Executive Officer | Jan 17, 2023 | Sale | $5.49 | 3,691 | 20,264 | 313,106 | Jan 18, 2023, 07:04 PM |
Hager Alicia J. | Chief Legal Officer | Jan 17, 2023 | Sale | $5.49 | 1,103 | 6,055 | 57,197 | Jan 18, 2023, 07:04 PM |
Brandenberger Ralph | Chief Technical Officer | Jan 17, 2023 | Sale | $5.49 | 491 | 2,696 | 28,309 | Jan 18, 2023, 07:03 PM |
Brandenberger Ralph | Chief Technical Officer | Oct 06, 2022 | Option Exercise | $3.89 | 842 | 3,275 | 8,642 | Oct 07, 2022, 06:44 PM |
Brandenberger Ralph | Chief Technical Officer | Oct 06, 2022 | Sale | $14.02 | 842 | 11,805 | 7,800 | Oct 07, 2022, 06:44 PM |
HASTINGS PAUL J | Chief Executive Officer | Sep 29, 2022 | Sale | $13.00 | 498 | 6,474 | 250,461 | Sep 30, 2022, 04:30 PM |
HASTINGS PAUL J | Chief Executive Officer | Sep 28, 2022 | Sale | $13.03 | 23,376 | 304,615 | 250,959 | Sep 30, 2022, 04:30 PM |
HASTINGS PAUL J | Chief Executive Officer | Sep 21, 2022 | Sale | $13.01 | 6,126 | 79,717 | 274,335 | Sep 22, 2022, 05:32 PM |
Trager James | Chief Scientific Officer | Aug 15, 2022 | Option Exercise | $3.89 | 5,000 | 19,450 | 67,172 | Aug 17, 2022, 04:21 PM |
Trager James | Chief Scientific Officer | Aug 15, 2022 | Sale | $17.53 | 5,000 | 87,655 | 62,172 | Aug 17, 2022, 04:21 PM |
Brandenberger Ralph | Chief Technical Officer | Aug 15, 2022 | Option Exercise | $3.89 | 11,000 | 42,790 | 18,800 | Aug 17, 2022, 04:20 PM |
Brandenberger Ralph | Chief Technical Officer | Aug 15, 2022 | Sale | $17.64 | 11,000 | 194,052 | 7,800 | Aug 17, 2022, 04:20 PM |
Mahmood Nadir | See Remarks | Aug 15, 2022 | Option Exercise | $3.89 | 7,500 | 29,175 | 53,588 | Aug 17, 2022, 04:17 PM |
Mahmood Nadir | See Remarks | Aug 15, 2022 | Sale | $18.03 | 7,500 | 135,215 | 46,088 | Aug 17, 2022, 04:17 PM |
Brandenberger Ralph | Chief Technical Officer | Aug 08, 2022 | Option Exercise | $2.60 | 11,593 | 30,199 | 19,393 | Aug 10, 2022, 07:05 PM |
Brandenberger Ralph | Chief Technical Officer | Aug 08, 2022 | Sale | $15.51 | 11,593 | 179,783 | 7,800 | Aug 10, 2022, 07:05 PM |
Mahmood Nadir | See Remarks | Aug 08, 2022 | Option Exercise | $3.89 | 7,500 | 29,175 | 53,588 | Aug 10, 2022, 07:03 PM |
Mahmood Nadir | See Remarks | Aug 08, 2022 | Sale | $15.32 | 7,500 | 114,900 | 46,088 | Aug 10, 2022, 07:03 PM |
Brandenberger Ralph | Chief Technical Officer | Jul 25, 2022 | Option Exercise | $0.41 | 3,000 | 1,230 | 10,800 | Jul 26, 2022, 08:15 PM |
Brandenberger Ralph | Chief Technical Officer | Jul 25, 2022 | Sale | $13.41 | 3,000 | 40,230 | 7,800 | Jul 26, 2022, 08:15 PM |
Mahmood Nadir | See Remarks | Jul 25, 2022 | Option Exercise | $3.89 | 7,500 | 29,175 | 53,588 | Jul 26, 2022, 08:14 PM |
Mahmood Nadir | See Remarks | Jul 25, 2022 | Sale | $13.40 | 7,500 | 100,480 | 46,088 | Jul 26, 2022, 08:14 PM |
Brandenberger Ralph | Sr. VP, Technical Operations | Jun 03, 2022 | Option Exercise | $3.69 | 4,140 | 15,278 | 9,440 | Jun 07, 2022, 04:01 PM |
Brandenberger Ralph | Sr. VP, Technical Operations | Jun 03, 2022 | Sale | $15.00 | 4,140 | 62,100 | 5,300 | Jun 07, 2022, 04:01 PM |
George Simeon | Director | Apr 28, 2022 | Buy | $15.00 | 1,333,333 | 19,999,995 | 666,667 | Apr 29, 2022, 04:27 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Apr 26, 2022 | Buy | $15.00 | 2,200,000 | 33,000,000 | 7,805,129 | Apr 28, 2022, 04:32 PM |
Brandenberger Ralph | Sr. VP, Technical Operations | Dec 01, 2021 | Option Exercise | $3.69 | 4,140 | 15,278 | 4,140 | Dec 03, 2021, 05:02 PM |
Brandenberger Ralph | Sr. VP, Technical Operations | Dec 01, 2021 | Sale | $15.64 | 4,140 | 64,750 | 0 | Dec 03, 2021, 05:02 PM |
HASTINGS PAUL J | Chief Executive Officer | Sep 29, 2021 | Sale | $27.18 | 8,500 | 231,051 | 219,284 | Oct 01, 2021, 04:35 PM |
Brandenberger Ralph | See Remarks | Sep 01, 2021 | Option Exercise | $3.69 | 4,140 | 15,278 | 4,140 | Sep 02, 2021, 08:52 PM |
Brandenberger Ralph | See Remarks | Sep 01, 2021 | Sale | $32.08 | 4,140 | 132,811 | 0 | Sep 02, 2021, 08:52 PM |
Rajangam Kanya | Chief Medical Officer | Aug 05, 2021 | Option Exercise | $0.41 | 10,000 | 4,100 | 10,000 | Aug 09, 2021, 05:17 PM |
Rajangam Kanya | Chief Medical Officer | Aug 05, 2021 | Sale | $37.28 | 10,000 | 372,800 | 0 | Aug 09, 2021, 05:17 PM |
Trager James | Chief Scientific Officer | Aug 02, 2021 | Option Exercise | $3.89 | 2,250 | 8,753 | 47,972 | Aug 04, 2021, 04:50 PM |
Trager James | Chief Scientific Officer | Aug 02, 2021 | Sale | $31.53 | 3,600 | 113,508 | 44,372 | Aug 04, 2021, 04:50 PM |
Mahmood Nadir | See Remarks | Jul 01, 2021 | Option Exercise | $3.89 | 3,500 | 13,615 | 33,788 | Jul 06, 2021, 05:11 PM |
Mahmood Nadir | See Remarks | Jul 01, 2021 | Sale | $31.71 | 6,500 | 206,115 | 27,288 | Jul 06, 2021, 05:11 PM |
HASTINGS PAUL J | Chief Executive Officer | Jun 21, 2021 | Sale | $26.61 | 8,500 | 226,218 | 231,368 | Jun 23, 2021, 04:05 PM |
Brandenberger Ralph | See Remarks | Jun 02, 2021 | Option Exercise | $3.69 | 4,140 | 15,278 | 4,140 | Jun 04, 2021, 02:29 PM |
Brandenberger Ralph | See Remarks | Jun 02, 2021 | Sale | $24.50 | 4,140 | 101,430 | 0 | Jun 04, 2021, 02:29 PM |
HASTINGS PAUL J | Chief Executive Officer | Mar 30, 2021 | Sale | $30.74 | 17,000 | 522,540 | 241,600 | Apr 01, 2021, 06:15 AM |
Trager James | Chief Scientific Officer | Feb 02, 2021 | Option Exercise | $18.00 | 2,800 | 50,400 | 49,872 | Feb 03, 2021, 07:48 PM |
Trager James | Chief Scientific Officer | Feb 01, 2021 | Option Exercise | $3.89 | 2,250 | 8,753 | 50,672 | Feb 03, 2021, 07:48 PM |
Trager James | Chief Scientific Officer | Feb 02, 2021 | Sale | $40.00 | 2,800 | 112,000 | 47,072 | Feb 03, 2021, 07:48 PM |
Trager James | Chief Scientific Officer | Feb 01, 2021 | Sale | $38.67 | 3,600 | 139,229 | 48,638 | Feb 03, 2021, 07:48 PM |
Mahmood Nadir | See Remarks | Jan 25, 2021 | Option Exercise | $3.89 | 5,500 | 21,395 | 36,988 | Jan 26, 2021, 04:10 PM |
Mahmood Nadir | See Remarks | Jan 25, 2021 | Sale | $48.57 | 5,500 | 267,120 | 34,988 | Jan 26, 2021, 04:10 PM |
Mahmood Nadir | See Remarks | Jan 14, 2021 | Option Exercise | $3.89 | 3,083 | 11,993 | 31,488 | Jan 19, 2021, 10:06 AM |
Mahmood Nadir | See Remarks | Dec 03, 2020 | Option Exercise | $3.89 | 3,000 | 11,670 | 28,405 | Dec 07, 2020, 08:27 PM |
GLAXOSMITHKLINE PLC | Director | Jul 14, 2020 | Buy | $18.00 | 833,333 | 14,999,994 | 3,150,732 | Jul 16, 2020, 08:13 PM |
New Enterprise Associates 15, L.P. | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
SANDELL SCOTT D | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
Sonsini Peter W. | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
Makhzoumi Mohamad | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
BASKETT FOREST | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
MAKOWER JOSHUA | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
Florence Anthony A. Jr. | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 666,666 | 11,999,988 | 2,902,115 | Jul 16, 2020, 05:00 PM |
Novo Holdings A/S | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 555,555 | 9,999,990 | 2,793,865 | Jul 16, 2020, 04:41 PM |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 3,333,333 | 59,999,994 | 5,605,129 | Jul 16, 2020, 04:30 PM |
Flynn James E | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 500,000 | 9,000,000 | 1,209,936 | Jul 14, 2020, 11:39 AM |
Flynn James E | 10% Owner | Jul 14, 2020 | Buy | $18.00 | 500,000 | 9,000,000 | 1,209,936 | Jul 14, 2020, 11:39 AM |
Owner | Relationship | Date | Value($) |
HASTINGS PAUL J | Chief Executive Officer | 03/04/2024 | 1,834,768 |
HASTINGS PAUL J | Chief Executive Officer | 03/01/2024 | 160,654 |
Brandenberger Ralph | Chief Technical Officer | 03/01/2024 | 26,308 |
Brandenberger Ralph | Chief Technical Officer | 03/01/2024 | 104,671 |
Trager James | Chief Scientific Officer | 02/12/2024 | 49,716 |
Shook David | Chief Medical Officer | 01/16/2024 | 31,044 |
Trager James | Chief Scientific Officer | 01/16/2024 | 39,854 |
Brandenberger Ralph | Chief Technical Officer | 01/16/2024 | 21,955 |
HASTINGS PAUL J | Chief Executive Officer | 01/16/2024 | 84,752 |
Hager Alicia J. | Chief Legal Officer | 01/16/2024 | 39,802 |
Shook David | Chief Medical Officer | 08/21/2023 | 2,436 |
Trager James | Chief Scientific Officer | 06/20/2023 | 2,129 |
Brandenberger Ralph | Chief Technical Officer | 06/20/2023 | 1,072 |
Hager Alicia J. | Chief Legal Officer | 06/20/2023 | 3,400 |
Shook David | Chief Medical Officer | 06/20/2023 | 2,129 |
Mahmood Nadir | See Remarks | 06/20/2023 | 2,551 |
HASTINGS PAUL J | Chief Executive Officer | 06/20/2023 | 8,264 |
Trager James | Chief Scientific Officer | 01/17/2023 | 6,121 |
Shook David | Chief Medical Officer | 01/17/2023 | 961 |
Mahmood Nadir | See Remarks | 01/17/2023 | 6,160 |
HASTINGS PAUL J | Chief Executive Officer | 01/17/2023 | 20,264 |
Hager Alicia J. | Chief Legal Officer | 01/17/2023 | 6,055 |
Brandenberger Ralph | Chief Technical Officer | 01/17/2023 | 2,696 |
Brandenberger Ralph | Chief Technical Officer | 10/06/2022 | 3,275 |
Brandenberger Ralph | Chief Technical Officer | 10/06/2022 | 11,805 |
HASTINGS PAUL J | Chief Executive Officer | 09/29/2022 | 6,474 |
HASTINGS PAUL J | Chief Executive Officer | 09/28/2022 | 304,615 |
HASTINGS PAUL J | Chief Executive Officer | 09/21/2022 | 79,717 |
Trager James | Chief Scientific Officer | 08/15/2022 | 19,450 |
Trager James | Chief Scientific Officer | 08/15/2022 | 87,655 |
Brandenberger Ralph | Chief Technical Officer | 08/15/2022 | 42,790 |
Brandenberger Ralph | Chief Technical Officer | 08/15/2022 | 194,052 |
Mahmood Nadir | See Remarks | 08/15/2022 | 29,175 |
Mahmood Nadir | See Remarks | 08/15/2022 | 135,215 |
Brandenberger Ralph | Chief Technical Officer | 08/08/2022 | 30,199 |
Brandenberger Ralph | Chief Technical Officer | 08/08/2022 | 179,783 |
Mahmood Nadir | See Remarks | 08/08/2022 | 29,175 |
Mahmood Nadir | See Remarks | 08/08/2022 | 114,900 |
Brandenberger Ralph | Chief Technical Officer | 07/25/2022 | 1,230 |
Brandenberger Ralph | Chief Technical Officer | 07/25/2022 | 40,230 |
Mahmood Nadir | See Remarks | 07/25/2022 | 29,175 |
Mahmood Nadir | See Remarks | 07/25/2022 | 100,480 |
Brandenberger Ralph | Sr. VP, Technical Operations | 06/03/2022 | 15,278 |
Brandenberger Ralph | Sr. VP, Technical Operations | 06/03/2022 | 62,100 |
George Simeon | Director | 04/28/2022 | 19,999,995 |
RA CAPITAL MANAGEMENT, L.P. | Director | 04/26/2022 | 33,000,000 |
Brandenberger Ralph | Sr. VP, Technical Operations | 12/01/2021 | 15,278 |
Brandenberger Ralph | Sr. VP, Technical Operations | 12/01/2021 | 64,750 |
HASTINGS PAUL J | Chief Executive Officer | 09/29/2021 | 231,051 |
Brandenberger Ralph | See Remarks | 09/01/2021 | 15,278 |
Brandenberger Ralph | See Remarks | 09/01/2021 | 132,811 |
Rajangam Kanya | Chief Medical Officer | 08/05/2021 | 4,100 |
Rajangam Kanya | Chief Medical Officer | 08/05/2021 | 372,800 |
Trager James | Chief Scientific Officer | 08/02/2021 | 8,753 |
Trager James | Chief Scientific Officer | 08/02/2021 | 113,508 |
Mahmood Nadir | See Remarks | 07/01/2021 | 13,615 |
Mahmood Nadir | See Remarks | 07/01/2021 | 206,115 |
HASTINGS PAUL J | Chief Executive Officer | 06/21/2021 | 226,218 |
Brandenberger Ralph | See Remarks | 06/02/2021 | 15,278 |
Brandenberger Ralph | See Remarks | 06/02/2021 | 101,430 |
HASTINGS PAUL J | Chief Executive Officer | 03/30/2021 | 522,540 |
Trager James | Chief Scientific Officer | 02/02/2021 | 50,400 |
Trager James | Chief Scientific Officer | 02/01/2021 | 8,753 |
Trager James | Chief Scientific Officer | 02/02/2021 | 112,000 |
Trager James | Chief Scientific Officer | 02/01/2021 | 139,229 |
Mahmood Nadir | See Remarks | 01/25/2021 | 21,395 |
Mahmood Nadir | See Remarks | 01/25/2021 | 267,120 |
Mahmood Nadir | See Remarks | 01/14/2021 | 11,993 |
Mahmood Nadir | See Remarks | 12/03/2020 | 11,670 |
GLAXOSMITHKLINE PLC | Director | 07/14/2020 | 14,999,994 |
New Enterprise Associates 15, L.P. | 10% Owner | 07/14/2020 | 11,999,988 |
SANDELL SCOTT D | 10% Owner | 07/14/2020 | 11,999,988 |
Sonsini Peter W. | 10% Owner | 07/14/2020 | 11,999,988 |
Makhzoumi Mohamad | 10% Owner | 07/14/2020 | 11,999,988 |
BASKETT FOREST | 10% Owner | 07/14/2020 | 11,999,988 |
MAKOWER JOSHUA | 10% Owner | 07/14/2020 | 11,999,988 |
Florence Anthony A. Jr. | 10% Owner | 07/14/2020 | 11,999,988 |
Novo Holdings A/S | 10% Owner | 07/14/2020 | 9,999,990 |
RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 07/14/2020 | 59,999,994 |
Flynn James E | 10% Owner | 07/14/2020 | 9,000,000 |
Flynn James E | 10% Owner | 07/14/2020 | 9,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 7,805,129 | 0.8% | No change | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,450,000 | 0.05% | 2376.67% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,400,000 | 0.41% | New | Other |
BLACKROCK INC. | 2,599,201 | 0.00044% | -10.06% | Other |
RENAISSANCE TECHNOLOGIES LLC | 657,772 | 0.00672% | 28.33% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 653,740 | 0.00045% | 3.32% | Other |
ALPINE GLOBAL MANAGEMENT, LLC | 57,022 | 0.04% | Exited | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View